{"id":130,"date":"2019-01-29T15:27:04","date_gmt":"2019-01-29T06:27:04","guid":{"rendered":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol-test\/?page_id=130"},"modified":"2026-02-12T11:19:00","modified_gmt":"2026-02-12T02:19:00","slug":"shoutai","status":"publish","type":"page","link":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/publications\/shoutai\/","title":{"rendered":"\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u30fb\u62db\u5f85\u8b1b\u6f14"},"content":{"rendered":"

2025<\/h4>\n
    \n
  1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1aIOC\u7642\u6cd5\u7814\u7a76\u4f1a\u5b9a\u671f\u96c6\u4f1a2026, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u708e\u75c7\u6027\u5f62\u8cea\u3068\u304c\u3093\u6cbb\u7642\u201d, 2026.2.6\uff08\u798f\u5cf6\u958b\u50ac, Web\u63a5\u7d9a\u306b\u3066\u30ea\u30e2\u30fc\u30c8\u8b1b\u6f14\uff09<\/li>\n
  2. Hida K<\/u>\uff1a2025 Annual Meeting of the Korean Society for Vascular Biology and Medicine (KVBM), \u201cTumor Endothelial Cells and Cancer-Associated Thrombosis\u201d, 2025.11.8, Daejeon, Korea<\/li>\n
  3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c80\u56de\u5275\u6210\u5dddDC\uff08dental conference\uff09, \u201c\u8840\u7ba1\u3068\u304c\u3093\u306e\u9032\u5c55\u201d, 2025.10.8\uff08\u672d\u5e4c\uff09<\/li>\n
  4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c84\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30b8\u30e7\u30a4\u30f3\u30c8\u30b7\u30f3\u30dd\u30b8\u30a6\u30e05, \u201c\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u708e\u75c7\u8001\u5316\u3068\u304c\u3093\u306e\u9032\u5c55\u201d,2025.9.27\uff08\u91d1\u6ca2\uff09<\/li>\n
  5. \u677e\u7530\u3000\u5f69, \u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c36\u56de\u65e5\u672c\u81e8\u5e8a\u53e3\u8154\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201c\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u306e\u7570\u5e38\u6027\u201d, 2025.9.3\uff08\u5ca1\u5c71\uff09<\/li>\n
  6. \u6a0b\u7530\u4eac\u5b50<\/u>, \u9593\u77f3\u5948\u6e56, \u677e\u7530\u2007\u5f69\uff1a \u7b2c67\u56de \u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u5148\u7aef\u6b6f\u5b66\u56fd\u969b\u6559\u80b2\u7814\u7a76\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff08ADS\uff09\u300c\u5fae\u5c0f\u74b0\u5883\u306e\u7406\u89e3\u3092\u901a\u3058\u305f\u53e3\u8154\u304c\u3093\u306e\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u300d,\u201c\u816b\u760d\u5185\u76ae\u7d30\u80de\u306b\u3088\u308b\u764c\u306e\u8ee2\u79fb\u4fc3\u9032\u201d, 2025.9.7\uff08\u5317\u4e5d\u5dde\u5e02\uff09<\/li>\n
  7. Hida K:<\/span>The 43<\/span>rd<\/span> Sapporo International Cancer Symposium, \u201cContribution of tumor vascular endothelial cell abnormality in cancer progression\u201d, 2025.7.6, Sapporo<\/span><\/li>\n
  8. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u7b2c29\u56de\u65e5\u672c\u304c\u3093\u5206\u5b50\u6a19\u7684\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \u79d1\u5b66\u8005\u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201c\u816b\u760d\u5185\u76ae\u7d30\u80de\u3068\u764c\u95a2\u9023\u8840\u6813\u75c7\u201d, 2025.7.4\uff08\u672d\u5e4c\uff09<\/span><\/li>\n
  9. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u7b2c50\u56de\u5fae\u5c0f\u5faa\u74b0\u5b66\u4f1a\u30fb\u7b2c78\u56de\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u5b66\u4f1a\u3000\u5408\u540c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\u300c\u53e3\u8154\u79d1\u5b66\u3068\u5fae\u5c0f\u5faa\u74b0\u30fb\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u300d, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u708e\u75c7\u8001\u5316\u201d, 2025.5.22\uff08\u5c0f\u7530\u539f\uff09<\/span><\/li>\n<\/ol>\n

    2024<\/h4>\n
      \n
    1. \u6a0b\u7530\u4eac\u5b50\uff1a\u7b2c66\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a \u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u30e9\u30a4\u30aa\u30f3\u5b66\u8853\u8cde\u53d7\u8cde\u8b1b\u6f14, \u201c\u304c\u3093\u95a2\u9023\u8840\u6813\u75c7\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u5f79\u5272\u306e\u89e3\u660e\u201d, 2024.11.3\uff08\u9577\u5d0e\uff09<\/li>\n
    2. \u6a0b\u7530\u4eac\u5b50\uff1a\u7b2c66\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u30b7\u30f3\u30dd\u30b8\u30a6\u30e05, \u201d \u9ad8\u8ee2\u79fb\u6027\u816b\u760d\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306e\u7570\u5e38\u6027\u7372\u5f97\u201d,2024.11.3\uff08\u9577\u5d0e\uff09<\/li>\n
    3. \u6a0b\u7530\u4eac\u5b50: \u7b2c83\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201cTumor endothelial cells and cancer-associated thrombosis\u201d, 2024.9.21\uff08\u798f\u5ca1\uff09<\/li>\n
    4. Hida K<\/span>: 2024 KSBC-Hokkaido University Joint Symposium on Bioconvergence, \u201cThe role of tumor\u00a0endothelial cells\u00a0in cancer metastasis\u201d, 2024,8,28, Sapporo<\/span><\/li>\n
    5. Li Yu: 2024 KSBC-Hokkaido University Joint Symposium on Bioconvergence, \u201cTumor endothelial cells\u00a0and cancer-associated thrombosis\u201d, 2024,8,28, Sapporo<\/span><\/li>\n
    6. Yu Li, Kyoko Hida<\/u>\uff1aVascular inflammation and tumor metastasis\uff0c\u7b2c33\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a. 2024.6.27(\u5948\u826f)<\/li>\n
    7. \u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c9\u56de\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u82e5\u624b\u7814\u7a76\u4f1a, \u201c\u304c\u3093\u304b\u3089\u611f\u67d3\u75c7\u307e\u3067\uff1a\u816b\u760d\u8840\u7ba1\u7814\u7a76\u304c\u5c0e\u304f\u65b0\u305f\u306a\u767a\u898b\u201d, 2024.6.14,\uff08\u6771\u4eac\uff09<\/span><\/li>\n<\/ol>\n

      2023<\/h4>\n
        \n
      1. \u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c113\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a, \u5148\u7aef\u7684\u5206\u5b50\u75c5\u7406\u5b66\u8b1b\u7fd2\u4f1a\u3000\u5206\u5b50\u816b\u760d\u75c5\u7406\u5b66\u306e\u65b0\u5c55\u958b, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u3068\u708e\u75c7\u8001\u5316\u201d, 2024.3.28, \u540d\u53e4\u5c4b<\/span><\/li>\n
      2. \u6a0b\u7530\u4eac\u5b50<\/span>: \u85e4\u7530\u533b\u79d1\u5927\u5b66\u30002023\u5e74\u5ea6\u7b2c9\u56de\u533b\u5b66\u8b1b\u6f14, \u201c\u8840\u7ba1\u304b\u3089\u8003\u3048\u308b\u304c\u3093\u8ee2\u79fb\u3068COVID19\u91cd\u75c7\u5316\u306e\u5236\u5fa1\u201d, 2024.3.26, \u611b\u77e5\u770c\u8c4a\u660e\u5e02<\/span><\/li>\n
      3. Hida K: The 1st International Symposium on Cancer Immunology and Immunotherapy, \u201cContribution of tumor endothelial cells in tumor progression\u201d, 2024.3.23, Sapporo<\/li>\n
      4. \u6a0b\u7530\u4eac\u5b50: \u4eac\u90fd\u5927\u5b66\u533b\u751f\u7269\u5b66\u7814\u7a76\u6240\u3000\u518d\u751f\u7d44\u7e54\u69cb\u7bc9\u7814\u7a76\u90e8\u9580 \u751f\u4f53\u6750\u6599\u5b66\u5206\u91ce\u30bb\u30df\u30ca\u30fc, \u201c\u816b\u760d\u8840\u7ba1\u306e\u7570\u5e38\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d, 2024.1.16\uff08Web\u958b\u50ac\uff09<\/li>\n
      5. \u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c42\u56de\u65e5\u672c\u53e3\u8154\u816b\u760d\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\u7279\u8a2d\u8b1b\u6f14, \u201c\u8840\u7ba1\u75c5\u614b\u7814\u7a76\u304b\u3089\u304c\u3093\u81e8\u5e8a\u3078\u306e\u5c55\u958b\u306e\u8a66\u307f\u201d, 2024.1.26\uff08\u672d\u5e4c\uff09<\/span><\/li>\n
      6. \u6a0b\u7530\u4eac\u5b50: \u91d1\u6ca2\u5927\u5b66\u304c\u3093\u9032\u5c55\u5236\u5fa1\u7814\u7a76\u6240\u30bb\u30df\u30ca\u30fc, \u201c\u816b\u760d\u8840\u7ba1\u306e\u708e\u75c7\u8001\u5316\u201d, 2023.11.6\uff08\u91d1\u6ca2\uff09<\/span><\/li>\n
      7. Yu Li: \u7b2c127\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u5968\u52b1\u8cde\u53d7\u8cde\u8a18\u5ff5\u8b1b\u6f14\uff0c\u201cThe oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation\u201d Cancer Sci, 113(11): 3980\u20133994, 2022\uff0c2023.11.11\uff08\u672d\u5e4c\uff09<\/span><\/strong><\/li>\n
      8. \u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c68\u56de\u65e5\u672c\u53e3\u8154\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u201c\u8840\u7ba1\u2015\u5fae\u5c0f\u74b0\u5883\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3068\u304c\u3093\u306e\u9032\u5c55\u201d, 2023.11.10, \u5927\u962a<\/span><\/li>\n
      9. \u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c64\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308b\u8840\u6813\u5f62\u6210\u4fc3\u9032\u201d, 2023.10.26, \u6a2a\u6d5c<\/span><\/li>\n
      10. Yu L,\u00a0 Maishi N, Akahori E, Hong Y, Hasebe A, Takeda R, Matsuda A, Hida Y, Kitagawa Y, Hida K: The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammati<\/span>on and thrombosis, Vascular Biology 2023,10.18, Newport, USA<\/span><\/li>\n
      11. \u68ee\u672c\u771f\u5f18, \u9593\u77f3\u5948\u6e56, \u5317\u5ddd\u5584\u653f, <\/span>\u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c10\u56de\u65e5\u672c\u7d30\u80de\u5916\u5c0f\u80de\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\uff1aEV\u3068\u8840\u7ba1, \u201c\u9ad8\u8ee2\u79fb\u6027\u816b\u760dEV\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306e\u7570\u5e38\u6027\u7372\u5f97\u201d, 2023.10.23, \u672d\u5e4c<\/span><\/li>\n
      12. \u6a0b\u7530\u4eac\u5b50<\/u>: \u7b2c88\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a \u6771\u90e8\u7dcf\u4f1a \u672d\u5e4c \u7279\u5225\u8b1b\u6f14, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u3068\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u201d, 2023.10.7, \u672d\u5e4c<\/li>\n
      13. \u9593\u77f3\u5948\u6e56, \u6a0b\u7530\u4eac\u5b50<\/u>: \u7b2c82\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb\u30bb\u30c3\u30b7\u30e7\u30f3\u300c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u3092\u6a19\u7684\u3068\u3057\u305f\u304c\u3093\u6cbb\u7642\u958b\u767a\u306e\u65b0\u5c55\u958b\u300d, \u201c\u304c\u3093\u3068\u8840\u7ba1\u306e\u30af\u30ed\u30b9\u30c8\u30fc\u30af\u3092\u6a19\u7684\u3068\u3057\u305f\u304c\u3093\u6cbb\u7642\u6226\u7565 \u201d , 2023.9.22, \u6a2a\u6d5c<\/li>\n
      14. Li Yu, Maishi N, Akahori E, Hasebe A, Takeda R, Yanagawa Matsuda A, Hida Y, Nam JM, Onodera Y, Kitagawa Y, Hida K<\/u>: \u7b2c82\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a [YSA]Cancer Science \u30e4\u30f3\u30b0\u30b5\u30a4\u30a8\u30f3\u30c6\u30a3\u30b9\u30c8\u30a2\u30ef\u30fc\u30c9\u53d7\u8cde\u8b1b\u6f14 \u201cThe oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation\u201d , \u00a09.21, \u6a2a\u6d5c<\/li>\n
      15. \u6a0b\u7530\u4eac\u5b50<\/u>: \u7b2c65\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201c\u816b\u760d\u8840\u7ba1\u5185\u88ab\u7d30\u80de\u306b\u3088\u308b\u304c\u3093\u8ee2\u79fb\u4fc3\u9032\u201d, 2023.9.17\uff08\u6771\u4eac\uff09<\/li>\n
      16. Yu L, Maishi N, Akahori E, Hasebe A, Takeda R, Matsuda A, Hida Y, Kitagawa Y, Hida K<\/u>, 2023 KVBM Annual Meeting & AAVBM in partnership with ICoLA, Korea-Japan young investigator session, The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation and thrombosis, 2023.9.14, Seoul, Korea<\/li>\n
      17. \u6a0b\u7530\u4eac\u5b50: \u7b2c41\u56de\u65e5\u672c\u30d2\u30c8\u7d30\u80de\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0,\u201c\u8840\u7ba1\u306e\u591a\u69d8\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d, 2023.8.26\uff08\u5ddd\u8d8a\uff09<\/span><\/li>\n
      18. \u6a0b\u7530\u4eac\u5b50: \u7b2c41\u56de\u65e5\u672c\u9aa8\u4ee3\u8b1d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201c\u304c\u3093, \u611f\u67d3\u75c7\u306b\u304a\u3051\u308b\u8840\u7ba1\u2015\u5fae\u5c0f\u74b0\u5883\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u201d, 2023.7.27\uff08\u6771\u4eac\uff09<\/span><\/li>\n
      19. \u9593\u77f3\u5948\u6e56, <\/span>\u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c32\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a\u3000\u5b66\u4f1a\u8cde\u53d7\u8cde\u8b1b\u6f14 <\/span>\u201c\u304c\u3093\u7d30\u80de\uff0d\u8840\u7ba1\u5185\u76ae\u7d30\u80deCluster\u5f62\u6210\u306b\u3088\u308b\u304c\u3093\u60aa\u6027\u5316\u4fc3\u9032\u201d, 2023.7.21\uff08\u4ed9\u53f0\uff09<\/li>\n
      20. \u6a0b\u7530\u4eac\u5b50<\/span>: \u7b2c43\u56de\u65e5\u672c\u9aa8\u5f62\u614b\u8a08\u6e2c\u5b66\u4f1a, \u201c\u764c\u5fae\u5c0f\u74b0\u5883\u3068\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u201d, 2023.6.30\uff08\u672d\u5e4c\uff09<\/span><\/li>\n
      21. Hida K<\/span>: The 2023 Conference of Asia Pacific Societies for Extracellular Vesicles\uff08APSEV\uff09, \u201cVasclar endothelial cell heterogeneity in diseases\u201d, 2023.4.1, Taipei<\/span><\/li>\n<\/ol>\n

        2022<\/h4>\n
          \n
        1. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u5317\u6d77\u9053DDS\u7814\u7a76\u4f1a\u3000\u516c\u958b\u7279\u5225\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201c \u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u591a\u69d8\u6027\u3068\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u201d, 2023.3.29\uff08\u672d\u5e4c\uff09<\/span><\/li>\n
        2. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u5317\u6d77\u9053\u767a\u7523\u5b98\u5b66\u30fb\u5730\u57df\u9023\u643a\u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u3000\u6570\u7406\u30fb\u30c7\u30fc\u30bf\u30b5\u30a4\u30a8\u30f3\u30b9\u3000\u7279\u5225\u30bb\u30c3\u30b7\u30e7\u30f3\u30fb\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7, \u201c\u8840\u7ba1\u306e\u591a\u69d8\u6027\uff5eWet\u306bdry\u3092\u53d6\u308a\u5165\u308c\u3066\u201d, 2023.2.24\uff08\u672d\u5e4c\uff09<\/span><\/li>\n
        3. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u65e5\u672c\u5973\u6027\u79d1\u5b66\u8005\u306e\u4f1a\u65b0\u6625\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02023\u3000\u5b66\u8853\u8b1b\u6f14\u4f1a,\u201c\u8840\u7ba1\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d 2023.1.7\uff08WEB\u958b\u50ac\uff09<\/span><\/li>\n
        4. \u9593\u77f3\u5948\u6e56\uff1a\u65e5\u672c\u5973\u6027\u79d1\u5b66\u8005\u306e\u4f1a\u3000\u5317\u6d77\u9053\u5927\u5b66\u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u30fb\u30a4\u30f3\u30af\u30eb\u30fc\u30b8\u30e7\u30f3\u63a8\u9032\u672c\u90e8\u5171\u50ac\u8b1b\u6f14\u4f1a\u3000\u5973\u6027\u7814\u7a76\u8005\u30ed\u30fc\u30eb\u30e2\u30c7\u30eb\u8b1b\u6f14\u4f1a\u300e\u8996\u5ea7\u3092\u9ad8\u3081, \u30ad\u30e3\u30ea\u30a2\u306eNEXT STEP\u3078\u300f, \u201c\u5973\u6027\u7814\u7a76\u8005\u304c\u5b50\u80b2\u3066\u3057\u306a\u304c\u3089\u7814\u7a76\u3092\u7d9a\u3051\u308b\u3068\u3044\u3046\u3053\u3068\u201d, 2023.1.7\uff08WEB\u958b\u50ac\uff09<\/span><\/li>\n
        5. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1aAIR\uff0dAngiogenesis & Immunology Research\uff0d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d\uff0c2022.12.13\uff08\u672d\u5e4c\uff09<\/span><\/li>\n
        6. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u9ce5\u53d6\u5927\u5b66\u533b\u5b66\u90e8\u7279\u5225\u8b1b\u7fa9\u3000\u7b2c41\u56de \u767a\u764c\u75c5\u7406\u5b66\u30bb\u30df\u30ca\u30fc, \u201c\u816b\u760d\u8840\u7ba1\u3068\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u201d, 2022.12.8\uff08WEB\u958b\u50ac\uff09<\/span><\/li>\n
        7. \u6a0b\u7530\u4eac\u5b50\uff1a\u7b2c45\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u516c\u52df\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u751f\u4f53\u7d44\u7e54\u306e\u5f62\u6210\u30fb\u518d\u751f\u30fb\u6052\u5e38\u6027\u7dad\u6301\u3068\u305d\u306e\u7834\u7dbb\u306b\u304a\u3051\u308b\u8840\u7ba1\u306e\u65b0\u305f\u306a\u6a5f\u80fd\u300d, \u201c\u304c\u3093\u3068\u611f\u67d3\u75c7\u306b\u304a\u3051\u308b\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u591a\u69d8\u6027, The heterogeneity of endothelial cells in tumor and infectious disease\u201d2022.12.2\uff08\u5e55\u5f35\uff09<\/span><\/li>\n
        8. Hida K<\/span>: Tumor endothelial cells induce metastasis by disrupting immune environment22nd International Vascular Biology Meeting (IVBM 2022) Session: Angiogenesis and Vascular Remodeling, 2022.10.15, Oakland, CA, USA<\/span><\/li>\n
        9. \u6a0b\u7530\u4eac\u5b50<\/span>: Gynecologic Cancer Clinical Research Seminar2022, \u201c\u816b\u760d\u8840\u7ba1\u3068\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u201d, 2022.10.5\uff08\u5ca1\u5c71\u958b\u50ac, Web\u63a5\u7d9a\u306b\u3066\u30ea\u30e2\u30fc\u30c8\u8b1b\u6f14\uff09<\/span><\/li>\n
        10. Hida K<\/span>: The 81st Annual Meeting of the Japanese Cancer Association, Cutting Edge Session, \u201cEpigenetic heterogeneity in tumor endothelial cells\uff08\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u304a\u3051\u308b\u30a8\u30d4\u30b2\u30ce\u30e0\u591a\u69d8\u6027\uff09\u201d, 2022.10.1\uff08\u6a2a\u6d5c\uff09<\/span><\/li>\n
        11. Maishi N, <\/span>Hida K<\/span>: The 81st Annual Meeting of the Japanese Cancer Association, International Sessions,\u201cPromotion of tumor metastasis by tumor endothelial cells\uff08\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308b\u8ee2\u79fb\u4fc3\u9032\uff09\u201d2022.9.30\uff08\u6a2a\u6d5c\uff09<\/span><\/li>\n
        12. Hida K<\/span>: The 81st Annual Meeting of the Japanese Cancer Association, JCA-AACR Joint Symposium -Sponsored by Princess Takamatsu Cancer Research Fund-, \u201cThe contribution of tumor endothelial cells in tumor progression\uff08\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u304c\u3082\u305f\u3089\u3059\u304c\u3093\u306e\u9032\u5c55\u3078\u306e\u5f71\u97ff\uff09\u201d2022.9.29\uff08\u6a2a\u6d5c\uff09<\/span><\/li>\n
        13. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u7b2c64\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a \u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u30b7\u30f3\u30dd\u30b8\u30a6\u30e05\u300c4\u6b6f\u79d1\u57fa\u790e\u9818\u57df\u306b\u304a\u3051\u308b\u304c\u3093\u7814\u7a76\u30d5\u30ed\u30f3\u30c6\u30a3\u30a2\u300d, \u201c\u816b\u760d\u8840\u7ba1\u5185\u88ab\u7d30\u80de\u306e\u7279\u6027\u3068\u304c\u3093\u514d\u75ab\u201d,\uff08\u8a8c\u4e0a\u767a\u8868\uff09<\/span><\/li>\n
        14. \u9593\u77f3\u5948\u6e56<\/span>\uff1a\u7b2c64\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u3000\u65e5\u672c\u5b66\u8853\u4f1a\u8b70\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff08\u5e02\u6c11\u516c\u958b\uff09Science Council of Japan Symposium\u300c\u53e3\u8154\u3068\u5168\u8eab\u306e\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\uff5e\u8108\u7ba1\u7cfb\u304b\u3089\u751f\u547d\u73fe\u8c61\u3092\u7406\u89e3\u3059\u308b\u300d, \u201c\u304c\u3093\u304a\u3088\u3073\u611f\u67d3\u75c7\u306b\u304a\u3051\u308b\u8840\u7ba1\u75c5\u614b\u306e\u89e3\u660e\u201d, 2022.9.17\uff08\u5fb3\u5cf6\uff09<\/span><\/li>\n
        15. \u9593\u77f3\u5948\u6e56\uff0c<\/span>\u6a0b\u7530\u4eac\u5b50<\/span>\uff1aThe 10th SaSSOH 2022 (Sapporo Summer Symposium for One Health), \u201cThe role of tumor endothelial cells in tumor progression\u201d, 2022. 9. 14, Hybrid<\/span>(Online and Lecture Building Faculty of Veterinary Medicine, Hokkaido University)<\/li>\n
        16. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u4e00\u822c\u793e\u56e3\u6cd5\u4eba \u65e5\u672c\u6b6f\u79d1\u533b\u5b66\u4f1a\u9023\u5408 \u4e3b\u50ac\u3000\u4ee4\u548c\uff14\uff082022)\u5e74\u5ea6 \u56fd\u969b\u6d3b\u52d5\u59d4\u54e1\u4f1a\u30d5\u30a9\u30fc\u30e9\u30e0\u201c\u305d\u3046\u3060\u7559\u5b66\u3001\u3057\u3088\u3046\uff01\uff5e\u9006\u8ee2\u306e\u767a\u60f3\uff01 \u65e5\u672c\u4eba\u3060\u304b\u3089\u3053\u305d\u7559\u5b66\u3057\u3088\u3046\uff5e\u201d, \u201c\u53cc\u5b50\u9023\u308c\u7559\u5b66\u4f53\u9a13\u8a18\uff5e\u30cf\u30f3\u30c7\u30a3\u304c\u3042\u3063\u3066\u3082\u306a\u3093\u3068\u304b\u306a\u308b\uff01\uff1f\u201d, \u30002022.9,12\uff08WEB\u958b\u50ac\uff09<\/span><\/li>\n
        17. \u9593\u77f3\u5948\u6e56\uff0c<\/span>\u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u306e\u7570\u5e38\u6027\u3068\u304c\u3093\u60aa\u6027\u5316, \u7b2c60\u56de\u65e5\u672c\u53e3\u8154\u79d1\u5b66\u4f1a\u5317\u65e5\u672c\u5730\u65b9\u90e8\u4f1a, 2022.7.10\uff08\u672d\u5e4c\uff09<\/span><\/li>\n
        18. Hida K<\/span>.: The 7th JCA\uff0dAACR Special Joint Conference\u201cThe Latest Advances in Pancreatic Cancer Research:From Basic Science to Therapeutics\u201d, \u201cContribution of tumor endotheilal cells in tumor progression\u201d, 2022. 7.9\uff08\u4eac\u90fd\uff09<\/span><\/li>\n
        19. Hida K<\/u>.: The 40th<\/sup> Sapporo International Cancer Symposium, \u201cThe impact of vascular endothelial cell heterogeneity in tumor microenvironment\u201d, 2022.6.25, Sapporo<\/li>\n
        20. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c59\u56de\u751f\u7269\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\u764c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201c\u304c\u3093\u3068\u8840\u7ba1\u306e\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u7406\u89e3\u3068\u65b0\u305f\u306a\u6cbb\u7642\u6226\u7565\u201d, 2022.6.24\uff08WEB\u958b\u50ac\uff09<\/li>\n
        21. \u6a0b\u7530\u4eac\u5b50\uff1a\u7b2c2\u56de\u8840\u7ba1\u7814\u7a76\u4f1a, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u304b\u3089\u764c\u514d\u75ab\u5fae\u5c0f\u74b0\u5883\u3078\u306e\u4f5c\u7528\u201d, 2022.2.22\uff08WEB\u958b\u50ac\uff09<\/li>\n
        22. \u9593\u77f3\u5948\u6e56\uff1a\u65e5\u672c\u85ac\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u7279\u5225\u8b1b\u6f14\u4f1a \u201c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u306e\u7279\u5fb4\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d, 2022.2.7\uff08WEB\u958b\u50ac\uff09<\/li>\n
        23. \u9593\u77f3\u5948\u6e56\uff1a\u56fd\u969b\u30aa\u30f3\u30e9\u30a4\u30f3\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0”Understanding of Novel Biological Phenomena in Cancer and Immunology Research”, \u201cThe role of tumor endothelial cells in tumor progression\u201d, 2022.1.27\uff08WEB\u958b\u50ac\uff09<\/li>\n
        24. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1aKCOG Scientific Seminar,\u201c\u816b\u760d\u8840\u7ba1\u3068\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u201d, 2022.1.23\uff08WEB\u958b\u50ac\uff09<\/li>\n
        25. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1aCABOMETYX Round TableMeeting in East Japan, \u201c\u816b\u760d\u8840\u7ba1\u3068\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306e\u30af\u30ed\u30b9\u30c8\u30fc\u30af\u201d, 2022.1.18\uff08WEB\u958b\u50ac\uff09<\/li>\n
        26. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u65e5\u672c\u5b66\u8853\u4f1a\u8b70\u6b6f\u5b66\u59d4\u54e1\u4f1a, \u75c5\u614b\u7cfb\u6b6f\u5b66\u5206\u79d1\u4f1a\u4e3b\u50ac, \u4e00\u822c\u8ca1\u56e3\u6cd5\u4eba\u65e5\u672c\u6b6f\u79d1\u533b\u5b66\u4f1a\u9023\u5408\u5171\u50ac\u516c\u958b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u201c\u6b6f\u5b66\u5206\u91ce\u306b\u304a\u3051\u308b\u30b8\u30a7\u30f3\u30c0\u30fc\u30fb\u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\uff5e\u8ab2\u984c\u3068\u5c55\u671b\u306b\u3064\u3044\u3066\uff5e\u201d, \u201c\u5973\u6027\u6d3b\u8e8d\u3078\u306e\u5c55\u671b\u301c\u5317\u6d77\u9053\u5927\u5b66\u6b6f\u5b66\u90e8\u306b\u304a\u3051\u308b\u7537\u5973\u5171\u540c\u53c2\u753b\u306e\u73fe\u72b6\u304b\u3089\u301c\u201d, 2022.1.13\uff08WEB\u958b\u50ac\uff09<\/li>\n<\/ol>\n

          2021<\/h4>\n
            \n
          1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c2\u56deOncology Crosstalk Symposium, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u3068\u304c\u3093\u514d\u75ab\u5fae\u5c0f\u74b0\u5883\u201d, 2021.12.18\uff08WEB\u958b\u50ac\uff09<\/li>\n
          2. \u9593\u77f3\u5948\u6e56, \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c66\u56de \u65e5\u672c\u53e3\u8154\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u4f1a\u5b66\u8853\u5927\u4f1a, \u201c\u304c\u3093\u306b\u304a\u3051\u308b\u8840\u7ba1\u306e\u5f79\u5272\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d, 2021.11.13\uff08WEB\u958b\u50ac\uff09<\/li>\n
          3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u9ce5\u53d6\u5927\u5b66\u533b\u5b66\u90e8\u30bb\u30df\u30ca\u30fc, \u201c\u816b\u760d\u8840\u7ba1\u3068\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u201d, 2021.11.11\uff08WEB\u958b\u50ac\uff09<\/li>\n
          4. \u9593\u77f3\u5948\u6e56, \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c63\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0c\u201d \u304c\u3093\u306e\u60aa\u6027\u5316\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u306e\u5f79\u5272\u201d\uff0c10.10\uff08WEB\u958b\u50ac\uff09<\/li>\n
          5. \u6a0b\u7530\u4eac\u5b50<\/span>\uff1a\u7b2c80\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u201d Metastasis: development of novel strategies through multifaceted understanding\u201d, \u201cThe role of tumor endothelial cells in cancer metastasis\u201d\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u7570\u5e38\u3068\u304c\u3093\u8ee2\u79fb\uff0c9.30\uff08\u6a2a\u6d5c\uff0cHybrid\u958b\u50ac\uff09<\/li>\n
          6. \u9593\u77f3\u5948\u6e56\uff1a\u7b2c32\u56de\u65e5\u672c\u81e8\u5e8a\u53e3\u8154\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\uff0c\u201d Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan\u201d\uff0c \u5968\u52b1\u8cde\u53d7\u8cde\u8005\u8b1b\u6f14, 2021.8.12\uff0c\u795e\u5948\u5ddd\u6b6f\u79d1\u5927\u5b66\u6a2a\u9808\u8cc0\u30ad\u30e3\u30f3\u30d1\u30b9(online)<\/li>\n
          7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c30\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u8840\u7ba1\u304b\u3089\u8ee2\u79fb\u3092\u8003\u3048\u308b\u300d\uff0c\u201d\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308b\u5fae\u5c0f\u74b0\u5883\u306e\u4e71\u308c\u3068\u304c\u3093\u306e\u8ee2\u79fb\u201d\uff0c2021.7.29\uff08WEB\u958b\u50ac\uff09<\/li>\n
          8. \u9593\u77f3\u5948\u6e56\uff1a\u7b2c121\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u6625\u5b63\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306e\u57fa\u790e\u3068\u81e8\u5e8a\u300d, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u3068\u304c\u3093\u306e\u60aa\u653f\u5316\u201d, 2021.6.26\uff08WEB\u958b\u50ac\uff09<\/li>\n
          9. \u6a0b\u7530\u4eac\u5b50<\/u>: \u7b2c4\u56deAIR in Sapporo\uff0dAngiogenesis & Immunology Research\uff0d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5236\u5fa1\u306b\u3088\u308b\u304c\u3093\u514d\u75ab\u6d3b\u6027\u5316\u201d\uff0c2021.6.1\uff08WEB\u958b\u50ac\uff09<\/li>\n
          10. \u6a0b\u7530\u4eac\u5b50<\/u>: \u7b2c110\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u304c\u3093\u3068\u514d\u75ab\u75c5\u7406, \u6700\u524d\u7dda\u300d,\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u304c\u3093\u514d\u75ab\u201d, 2021.4.24\uff08WEB\u958b\u50ac\uff09<\/li>\n
          11. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c94\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u5e74\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u7814\u7a76\u306e\u6700\u524d\u7dda\u3068\u5275\u85ac\u300d, \u201cThe Role of tumor endothelial cells in cancer progression\uff08\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\uff09\u201d, 2021.3.10\uff08WEB\u958b\u50ac\uff09<\/li>\n
          12. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5317\u6d77\u9053\u5927\u5b66\u75c5\u9662\u7537\u5973\u5171\u540c\u53c2\u753b\u63a8\u9032\u5ba4\u30fb\u5317\u6d77\u9053\u5927\u5b66\u5927\u5b66\u9662\u6b6f\u5b66\u7814\u7a76\u9662FD\u59d4\u54e1\u4f1a\u5171\u50ac\u3000\u7537\u5973\u5171\u540c\u53c2\u753b\u63a8\u9032\u5ba4\u8b1b\u6f14\u4f1a\u300c\u30ad\u30e3\u30ea\u30a2\u3092\u8003\u3048\u308b\u300d, \u201c\u79c1\u306eWork-Life Blend\u201d, 2021.3.1\uff08WEB\u958b\u50ac\uff09<\/li>\n<\/ol>\n

            2020<\/h4>\n
              \n
            1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u4ee4\u548c2\u5e74\u5ea6\u4e5d\u5dde\u5927\u5b66\u99ac\u51fa\u5730\u533a4\u90e8\u5c40\u5408\u540c\u7537\u5973\u5171\u540c\u53c2\u753bFD, \u201c\u79c1\u306e\u30ef\u30fc\u30af\u30e9\u30a4\u30d5\u30d0\u30e9\u30f3\u30b9\u3000\uff0dTry and Error\uff0d\u201d, 2020.11.27\uff08WEB\u958b\u50ac\uff09<\/li>\n
            2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u4ee4\u548c2\u5e74\u5ea6\u3000\u5f18\u524d\u5927\u5b66\u7b2c1\u56de\u751f\u4f53\u5fdc\u7b54\u79d1\u5b66\u7814\u7a76\u30bb\u30df\u30ca\u30fc, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d, 2020.11.25\uff08WEB\u958b\u50ac\uff09<\/li>\n
            3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1aBreast Cancer Investigator\u2019s Meeting in Sapporo, \u201c\u816b\u760d\u8840\u7ba1\u3068\u514d\u75ab\u5c0f\u74b0\u5883\u201d, 2020.11.18\uff08\u672d\u5e4c\uff09<\/li>\n
            4. \u9593\u2f6f\u5948\u6e56, \u83ca\u5730 \u592e, \u6a0b\u2f65 \u6cf0\u6d69, \u7be0\u539f\u4fe1\u96c4, \u6a0b<\/u>\u2f65<\/u>\u4eac<\/u>\u2f26<\/u>: \u6297\u764c\u5264\u6cbb\u7642\u304c\u3082\u305f\u3089\u3059\u816b\u760d\u8840\u7ba1\u30c8\u30e9\u30f3\u30b9\u30dd\u30fc\u30bf\u30fc\u767a\u73fe\u4ea2\u9032\u3068\u305d\u306e\u6a5f\u5e8f, \u4f9d\u983c\u8b1b\u6f14, \u7b2c6\u56de\u5317\u6d77\u9053\u5927\u5b66\u90e8\u5c40\u6a2a\u65ad\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u201c\u82e5\u624b\u7814\u7a76\u8005\u306b\u3088\u308b\u751f\u547d\u3068\u7269\u8cea\u306e\u878d\u5408\u3092\u76ee\u6307\u3057\u3066\uff01\u201d, 2020.10.19\uff08WEB\u958b\u50ac\uff09<\/li>\n
            5. Hossain E, Higashino F: Oncolytic virus utilizing RNA stabilization system, \u4f9d\u983c\u8b1b\u6f14, \u7b2c6\u56de\u5317\u6d77\u9053\u5927\u5b66\u90e8\u5c40\u6a2a\u65ad\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u201c\u82e5\u624b\u7814\u7a76\u8005\u306b\u3088\u308b\u751f\u547d\u3068\u7269\u8cea\u306e\u878d\u5408\u3092\u76ee\u6307\u3057\u3066\uff01\u201d, 2020.10.19\uff08WEB\u958b\u50ac\uff09<\/li>\n
            6. \u6a0b\u7530\u4eac\u5b50<\/u>: \u7b2c24\u56de\u65e5\u672c\u304c\u3093\u514d\u75ab\u5b66\u4f1a\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02\u300c\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u3068\u305d\u306e\u5236\u5fa1\u300d,\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u304c\u3093\u514d\u75ab\u201d, 2020.10.9\uff08\u672d\u5e4c\uff09<\/li>\n
            7. Hida K<\/u>: The 79th Annual Meeting of the Japanese Cancer Assosiation Symposium, Real world of tumor microenvironment, \u201cThe role of tumor endothelial cells in the immune environment\u201d, 2020.10.2, Hiroshima, Japan<\/li>\n
            8. \u6a0b\u7530\u4eac\u5b50<\/u>: \u7b2c79\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u7279\u5225\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u304c\u3093\u7814\u7a76\u306b\u304a\u3051\u308b\u5973\u6027\u7814\u7a76\u8005\uff08WSCR\uff09Women scientists in cancer research\u300d, \u201c\u6cbb\u7642\u6a19\u7684\u3068\u3057\u3066\u306e\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\u201d, 2020.10.1\uff08\u5e83\u5cf6\uff09<\/li>\n
            9. Hida K<\/u>: New Insights Into Drug-Resistance: Abnormality in Tumor Endothelial Cells, The 21th International Vascular Biology Meeting, 2020.9.11, Seoul, Korea<\/li>\n
            10. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c109\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u53e3\u8154\u816b\u760d\u306e\u75c5\u7406\u3068\u907a\u4f1d\u5b50\u7570\u5e38\u2015\u304c\u3093\u5f62\u8cea\u3068\u5fae\u5c0f\u74b0\u5883\u300d\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u89e3\u6790\u3068\u304c\u3093\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u201d 4.18\uff08\u798f\u5ca1\uff09<\/li>\n<\/ol>\n

              2019<\/h4>\n
                \n
              1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u65e5\u672c\u85ac\u7269\u52d5\u614b\u5b66\u4f1a\u7b2c34\u56de\u5e74\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e04\u300c\u8840\u7ba1\u3092\u6a19\u7684\u3068\u3057\u305fDDS\u306e\u6f6e\u6d41\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u201d\uff0c2019.12.10\uff08\u3064\u304f\u3070\uff09<\/li>\n
              2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c57\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u30b9\u30dd\u30f3\u30b5\u30fc\u30c9\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff14\u300c\u304c\u3093\u306e\u5897\u60aa\u30fb\u6d78\u6f64\u30fb\u8ee2\u79fb\u306b\u95a2\u308f\u308b\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306e\u91cd\u8981\u6027\u300d,\u201c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u5bfe\u3059\u308b\u5275\u85ac\u306e\u5e55\u958b\u3051\u201d,2019.10.25\uff08\u798f\u5ca1\uff09<\/li>\n
              3. \u9593\u77f3\u5948\u6e56, \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308bBiglycan\u306e\u5206\u6ccc\u3092\u4ecb\u3057\u305f\u304c\u3093\u306e\u8ee2\u79fb\u4fc3\u9032, \u7b2c61\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, 2019.10.12\uff08\u6771\u4eac\uff09<\/li>\n
              4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c60\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u59d4\u54e1\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12\u300c\u304c\u3093\u6cbb\u7642\uff5e\u8108\u7ba1\u3092\u653b\u3081\u308b\u3001\u8108\u7ba1\u3092\u5b88\u308b\u300d,\u201c\u6cbb\u7642\u6a19\u7684\u3068\u3057\u3066\u306e\u816b\u760d\u8840\u7ba1\u306e\u7279\u6027\u201d, 2019.10.10\uff08\u6771\u4eac\uff09<\/li>\n
              5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u9ad8\u77e5\u5927\u5b66\u3000DC\u30bb\u30df\u30ca\u30fc\u300c\u6b6f\u79d1\u53e3\u8154\u5916\u79d1\u5b66\u300d\uff0c10.4\uff08\u9ad8\u77e5\uff09<\/li>\n
              6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c30\u56de\u65e5\u672c\u81e8\u5e8a\u53e3\u8154\u75c5\u7406\u5b66\u4f1a\u5408\u540c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u53e3\u8154\u306b\u75c7\u72b6\u304c\u73fe\u308c\u308b\u5168\u8eab\u75be\u60a3\u3078\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u300d\uff0c\u201c\u8840\u7ba1\u65b0\u751f\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d\uff0c9.23\uff08\u6771\u4eac\uff09<\/li>\n
              7. Hida K<\/u>.\uff1aRoles of tumor endothelial cells in tumor progression, the 2019 AVBS SCIENTIFIC MEETING-JOINT VASCULAR BIOLOGY MEETING, 2019.9.20, Sydney, Australia<\/li>\n
              8. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u6587\u90e8\u79d1\u5b66\u7701\u65b0\u5b66\u8853\u9818\u57df\u7814\u7a76\u3000\u7d30\u80de\u793e\u4f1a\u30c0\u30a4\u30d0\u30fc\u30b9\u30b7\u30c6\uff0d\u306e\u7d71\u5408\u7684\u89e3\u660e\u3068\u5236\u5fa1_\u7b2c92\u56de\u65e5\u672c\u751f\u5316\u5b66\u4f1a\u5171\u50ac\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u81d3\u5668\u306e\u69cb\u7bc9\u3068\u5236\u5fa1\u306e\u7d71\u5408\u7684\u7406\u89e3\u3092\u76ee\u6307\u3057\u305f\u7d30\u80de\u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u30fc\u7814\u7a76\u300d\uff0c\u201c\u816b\u760d\u7d44\u7e54\u306e\u591a\u69d8\u6027\u3068\u76f8\u4e92\u4f5c\u7528\u201d\uff0c9.19\uff08\u6771\u4eac\uff09<\/li>\n
              9. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u4ee4\u548c\u5143\u5e74\u5317\u6d77\u9053\u5927\u5b66\u6b6f\u5b66\u90e8\u53e3\u8154\u5916\u79d1\u540c\u9580\u4f1a\u5b66\u8853\u5927\u4f1a\uff0c\u201c\u816b\u760d\u8840\u7ba1\u7814\u7a76\u3068\u4eca\u5f8c\u306e\u5c55\u671b\uff5eBench to Bed\u306e\u5b9f\u73fe\u306b\u3080\u3051\u3066\uff5e\u201d, 2019.9.14\uff08\u672d\u5e4c\uff09<\/li>\n
              10. Maishi N.\uff1aInternational Symposium between National Yang-Ming University and Hokkaido University, \u201cContribution of Tumor Endothelial Cells to Tumor Metastasis\u201d, 2019.8.11<\/li>\n
              11. \u9593\u77f3\u5948\u6e56\uff1a\u7b2c28\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a\u3000\u7814\u7a76\u5968\u52b1\u8cde\u8b1b\u6f14\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308bBiglycan\u306e\u5206\u6ccc\u3092\u4ecb\u3057\u305f\u304c\u3093\u306e\u8ee2\u79fb\u4fc3\u9032\u201d, 2019.7.26\uff08\u9e7f\u5150\u5cf6\uff09<\/li>\n
              12. Hida K.\uff1aAbnormalities of tumor endothelial cells and cancer progression, The 38th<\/sup> Sapporo International Cancer Symposium, 2019.7.12<\/li>\n
              13. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u6587\u90e8\u79d1\u5b66\u7701\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1\u3000\u65b0\u5b66\u8853\u9818\u57df\u7814\u7a76\u300c\u7d30\u80de\u793e\u4f1a\u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u306e\u7d71\u5408\u7684\u89e3\u660e\u3068\u5236\u5fa1\u300d\u7b2c\u56db\u56de\u516c\u958b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u3068\u305d\u306e\u5236\u5fa1\u201d\uff0c2019.6.27\uff08\u795e\u6238\uff09<\/li>\n
              14. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c119\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u6625\u5b63\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u304c\u3093\u514d\u75ab\u7642\u6cd5\uff1a\u57fa\u790e\u3068\u81e8\u5e8a\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u300d, \u201c\u816b\u760d\u514d\u75ab\u306b\u304a\u3051\u308b\u8840\u7ba1\u306e\u5f79\u5272\u201d, 2019.6.22\uff08\u672d\u5e4c\uff09<\/li>\n
              15. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c57\u56de\u65e5\u672c\u5c0f\u5150\u6b6f\u79d1\u5b66\u4f1a\u5927\u4f1a\uff0c\u300c\u5c06\u6765\u8a08\u753b\u691c\u8a0e\u59d4\u54e1\u4f1a\u30fb\u5973\u6027\u5c0f\u5150\u6b6f\u79d1\u533b\u59d4\u54e1\u4f1a\u5408\u540c\u4f01\u753b\u300d\uff0c\u201c\u79c1\u306e\u30ef\u30fc\u30af\u30e9\u30a4\u30d5\u30d0\u30e9\u30f3\u30b9\uff0d\u5b50\u9023\u308c\u7559\u5b66\uff0c\u30e9\u30dc\u30d8\u30c3\u30c9\u306e\u7d4c\u9a13\u304b\u3089\u5b66\u3093\u3060\u3082\u306e\u201d\uff0c6.10\uff08\u672d\u5e4c\uff09<\/li>\n
              16. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1aLung Cancer Expert Meeting in Sapporo, \u201cVEGF\u963b\u5bb3\u306b\u3088\u308b\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306e\u5236\u5fa1\u201d, 2019.5.17\uff08\u672d\u5e4c\uff09<\/li>\n
              17. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c108\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u3000\u7279\u5225\u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\u300c\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u3068\u75c5\u7406\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u907a\u4f1d\u5b50\u7570\u5e38\u201d\uff0c5.9\uff08\u6771\u4eac\uff09<\/li>\n
              18. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u814e\u764c\u306e\u8840\u7ba1\u3068\u514d\u75ab\u3092\u898b\u3064\u3081\u308b\u4f1a\uff0c\u201c\u816b\u760d\u8840\u7ba1\u65b0\u751f\u306e\u591a\u69d8\u6027\u3068\u814e\u764c\u306e\u60aa\u6027\u5316\u201d\uff0c2.1\uff08\u672d\u5e4c\uff09<\/li>\n<\/ol>\n

                2018<\/h4>\n
                  \n
                1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1aAIR in Sapporo\uff0dAngiogenesis & Immunology Research\uff0d\uff0c\u201c\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u3068\u5fae\u5c0f\u74b0\u5883\u306e\u5909\u5316\u201d\uff0c2018.11.3\uff08\u672d\u5e4c\uff09<\/li>\n
                2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u3053\u308c\u304b\u3089\u306e\u30ad\u30e3\u30ea\u30a2\u3092\u8a9e\u308b\u533b\u5e2b\u3068\u5b66\u751f\u306e\u4f1a2018\u8b1b\u6f14\u4f1a\u300c\u300e\u304c\u3093\u3068\u907a\u4f1d\u5b50\u300f\uff5e\u79c1\u305f\u3061\u306e\u7814\u7a76\u304c\u3001\u60a3\u8005\u3055\u3093\u306e\u672a\u6765\u3092\u5909\u3048\u308b\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u7279\u6027\u3092\u6d3b\u304b\u3057\u305f\u65b0\u3057\u3044\u304c\u3093\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3092\u76ee\u6307\u3057\u3066\u201d\uff0c2018.10.20\uff08\u672d\u5e4c\uff09<\/li>\n
                3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c77\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308b\u304c\u3093\u306e\u8ee2\u79fb\u4fc3\u9032\u201d\uff0c2018.9.27\uff08\u5927\u962a\uff09<\/li>\n
                4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c16\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u6d88\u5316\u5668\u764c\u306b\u5bfe\u3059\u308b\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u85ac\u306e\u610f\u7fa9\u300d\uff0c\u201c\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u306e\u5c55\u958b\u201d\uff0c2018.7.20\uff08\u795e\u6238\uff09<\/li>\n
                5. \u6a0b\u7530\u4eac\u5b50\uff1a\u7b2c107\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u3000\u7279\u5225\u4f01\u753b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306e\u75c5\u7406\u5b66\u300d\uff0c\u201c\u6cbb\u7642\u62b5\u6297\u6027\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u306e\u5f79\u5272\u201d\uff0c2018.6.23\uff08\u672d\u5e4c\uff09<\/li>\n
                6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5ba4\u862d\u5de5\u696d\u5927\u5b66\u300c\u30ad\u30e3\u30ea\u30a2\u5f62\u6210\u306e\u305f\u3081\u306e\u30e9\u30f3\u30c1\u30bf\u30a4\u30e0\u30bb\u30df\u30ca\u30fc\u7b2c10\u56de\u300d\uff0c\u201c\u7814\u7a76\u6307\u5c0e\u8005\u3068\u3057\u3066\u3001\u53cc\u5b50\u306e\u89aa\u3068\u3057\u3066\u201d\uff0c2018.6.18\uff08\u5ba4\u862d\uff09<\/li>\n<\/ol>\n

                  2017<\/h4>\n
                    \n
                  1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c25\u56de\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000AAVBM2017\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u201cTumor Angiogenesis and Lymphangiogenesis\u201d\uff0c\u201cChemotherapy-induced drug resistance in tumor endothelial cells\u201d\uff0c2017.12.10\uff08\u5927\u962a\uff09<\/li>\n
                  2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c40\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u751f\u8001\u75c5\u6b7b\u306b\u304a\u3051\u308b\u8840\u7ba1\u30fb\u30ea\u30f3\u30d1\u7ba1\u306e\u751f\u547d\u79d1\u5b66\u7684\u610f\u7fa9\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u5f62\u8cea\u5909\u5316\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d\uff0c2017.12.7\uff08\u795e\u6238\uff09<\/li>\n
                  3. \u9593\u77f3\u5948\u6e56\uff1a\u7b2c40\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u7d30\u80de\u5916\u5c0f\u80de\u9846\u7c92\u306f\u6211\u3005\u306b\u4f55\u3092\u8a9e\u308b\u304b\uff1f\uff5e\u7d30\u80de\u9593\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u304c\u7e54\u308a\u306a\u3059\u751f\u547d\u73fe\u8c61\u306e\u89e3\u660e\u3078\uff5e\u300d\uff0c\u201c\u9ad8\u8ee2\u79fb\u6027\u816b\u760dmiR\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306b\u304a\u3051\u308b\u85ac\u5264\u8010\u6027\u8a98\u5c0e\u201d\uff0c2017.12.7\uff08\u795e\u6238\uff09<\/li>\n
                  4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5e73\u621029\u5e74\u5ea6\u5148\u7aef\u533b\u5b66\u7814\u7a76\u30bb\u30df\u30ca\u30fc\uff08\u672d\u5e4c\u533b\u79d1\u5927\u5b66\uff09\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d2017.11.17\uff08\u672d\u5e4c\uff09<\/li>\n
                  5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c62\u56de\u65e5\u672c\u53e3\u8154\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\u7279\u5225\u30d7\u30ed\u30b0\u30e9\u30e0\u300c\u65e5\u53f0\u59c9\u59b9\u7de0\u7d5010\u5468\u5e74\u8a18\u5ff5\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3000Translational Research\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306b\u95a2\u3059\u308b\u57fa\u790e\u7814\u7a76\u304b\u3089\u65b0\u305f\u306a\u304c\u3093\u6cbb\u7642\u6226\u7565\u306e\u69cb\u7bc9\u3092\u76ee\u6307\u3057\u3066\u201d\uff0c2017.10.21\uff08\u4eac\u90fd\uff09<\/li>\n
                  6. \u9593\u77f3\u5948\u6e56\uff1a\u7b2c116\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u5968\u52b1\u8cde\u53d7\u8cde\u8a18\u5ff5\u8b1b\u6f14\uff0c\u201cTumor endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan\u201d\uff0c2017.10.21\uff08\u672d\u5e4c\uff09<\/li>\n
                  7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c76\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1aInternational Sessions\u300c\u304c\u3093\u8ee2\u79fb\u306b\u304a\u3051\u308b\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u7814\u7a76\u306e\u6700\u524d\u7dda\u300d\uff0c\u201c\u9ad8\u8ee2\u79fb\u6027\u816b\u760d\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306b\u304a\u3051\u308b\u85ac\u5264\u8010\u6027\u8a98\u5c0e\u201d\uff0c2017.9.28\uff08\u6a2a\u6d5c\uff09<\/li>\n
                  8. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c35\u56de\u65e5\u672c\u9aa8\u4ee3\u8b1d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u5171\u50ac\u30fb\u7b2c20\u56de\u764c\u3068\u9aa8\u75c5\u5909\u7814\u7a76\u4f1a\u3000\u30df\u30cb\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u764c\u3068\u9aa8\u75c5\u5909\u300d\u201c\u816b\u760d\u8840\u7ba1\u306e\u7570\u5e38\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d, 2017.7.29 (\u798f\u5ca1)<\/li>\n
                  9. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c26\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02\u300c\u304c\u3093\u5e79\u7d30\u80de\u306b\u5bfe\u3059\u308b\u65b0\u305f\u306a\u77e5\u898b\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u304c\u3093\u5e79\u7d30\u80de\u3078\u306e\u95a2\u4e0e\u201d\uff0c2017.7.28\uff08\u5927\u962a\uff09<\/li>\n
                  10. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u611b\u5a9b\u5927\u5b66\u30d7\u30ed\u30c6\u30aa\u30b5\u30a4\u30a8\u30f3\u30b9\u30bb\u30f3\u30bf\u30fc\u3000PROS\u30bb\u30df\u30ca\u30fc&\u5927\u5b66\u9662\u7279\u5225\u8b1b\u7fa9\u3000\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d\uff0c2017.6.12 \u00a0(\u611b\u5a9b)<\/li>\n<\/ol>\n

                    2016<\/h4>\n
                      \n
                    1. \u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c75\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u7279\u5225\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12\u300c\u764c\u7814\u7a76\u306b\u304a\u3051\u308b\u5973\u6027\u7814\u7a76\u8005\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308b\u304c\u3093\u8ee2\u79fb\u4fc3\u9032\u201d\uff0c2016.10.7\uff08\u6a2a\u6d5c\uff09<\/li>\n
                    2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c53\u56de\u5927\u962a\u5927\u5b66\u6570\u7406\u533b\u5b66\u7814\u7a76\u4f1a\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u7279\u6027\u89e3\u660e\u3068\u65b0\u3057\u3044\u304c\u3093\u6cbb\u7642\u6226\u7565\u201d\uff0c2016.9.28\uff08\u5927\u962a\u5e9c\u8c4a\u4e2d\u5e02\uff09<\/li>\n
                    3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5343\u91cc\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30bb\u30df\u30ca\u30fcK3\u300c\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u7814\u7a76\u306e\u6700\u524d\u7dda\uff1a\u75be\u60a3\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u89e3\u660e\u304b\u3089\u8a3a\u65ad\u30fb\u6cbb\u7642\u307e\u3067\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u7279\u7570\u6027\u3068\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u201d\uff0c2016.9.16\uff08\u5927\u962a\u5e9c\u8c4a\u4e2d\u5e02\uff09<\/li>\n
                    4. \u9593\u77f3 \u5948\u6e56\u3001\u6a0b\u7530<\/u>\u00a0<\/u>\u4eac\u5b50<\/u>\uff1a\u7b2c 69 \u56de\u65e5\u672c\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u3068\u767a\u304c\u3093\uff5e\u6700\u65b0\u306e\u77e5\u898b\uff5e\u300d\uff64\u201c\u6d3b\u6027\u9178\u7d20\u304c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u53ca\u307c\u3059\u5f71\u97ff\u201d\uff0c2016.8.31\uff08\u4ed9\u53f0\uff09<\/li>\n
                    5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff0c\u9593\u77f3\u5948\u6e56\uff1a\u7b2c58\u56de\u6b6f\u79d1\u57fa\u790e\u533b\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u300cA New Horizon for Oral Health Science\uff5e\u4e16\u754c\u306b\u98db\u8e8d\u3059\u308b\u30aa\u30fc\u30e9\u30eb\u30d8\u30eb\u30b9\u30b5\u30a4\u30a8\u30f3\u30b9\u306e\u6700\u524d\u7dda\uff5e\u300d\uff0c\u201c\u304c\u3093\u5fae\u5c11\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\u89e3\u660e\u3068\u305d\u306e\u5206\u5b50\u6a5f\u69cb\u201d\uff0c8.24\uff08\u672d\u5e4c\uff09<\/li>\n
                    6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff0c\u9593\u77f3\u5948\u6e56\uff1a\u7b2c25\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u304c\u3093\u8ee2\u79fb\u306e\u65b0\u3057\u3044\u6cbb\u7642\u6a19\u7684\u3068\u3057\u3066\u306e\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u7814\u7a76\u300d\uff0c\u201c\u9ad8\u8ee2\u79fb\u6027\u816b\u760dmiR\u306b\u3088\u308b\u8840\u7ba1\u5185\u76ae\u306b\u304a\u3051\u308b\u85ac\u5264\u8010\u6027\u8a98\u5c0e\u201d\uff0c2016.7.21\uff08\u7c73\u5b50\uff09<\/li>\n
                    7. \u9593\u77f3\u5948\u6e56\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u3088\u308b\u304c\u3093\u8ee2\u79fb\u4fc3\u9032\uff0c\u7b2c12\u56de\u5317\u6d77\u9053\u764c\u514d\u75ab\u5236\u5fa1\u7814\u7a76\u4f1a\uff0c2016.7.9\uff08\u672d\u5e4c\uff09<\/li>\n
                    8. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c70\u56de\u65e5\u672c\u53e3\u8154\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u300c\u53e3\u8154\u75be\u60a3\u6cbb\u7642\u306e\u79d1\u5b66\u9769\u547d\uff08\u30d1\u30e9\u30c0\u30a4\u30e0\u30b7\u30d5\u30c8\uff09\u300d\u6307\u540d\u5831\u544a,\u3000\u6f14\u984c\uff1a \u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\u89e3\u660e\u3068\u65b0\u305f\u306a\u304c\u3093\u6cbb\u7642\u3078\u306e\u5fdc\u7528, 2016.4.17\uff08\u798f\u5ca1\uff09<\/li>\n
                    9. Hida K<\/u>.\uff1aHeterogeneity of Tumor Endothelial Cells, Keystone Symposia on Molecular and Cellular Biology, 2016, 2016.4.1, Breckenridge, Colorado.<\/li>\n
                    10. \u6a0b\u7530\u4eac\u5b50<\/u>, \u9593\u77f3\u5948\u6e56, \u6a0b\u7530\u6cf0\u6d69\uff1a\u5e73\u621027\u5e74\u5ea6\u300c\u500b\u4f53\u30ec\u30d9\u30eb\u3067\u306e\u304c\u3093\u7814\u7a76\u652f\u63f4\u6d3b\u52d5\u300d\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d2015.2.3\uff08\u5927\u6d25\uff09<\/li>\n
                    11. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c34\u56de\u65e5\u672c\u53e3\u8154\u816b\u760d\u5b66\u4f1a\u7dcf\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u53e3\u8154\u304c\u3093\u306e\u6b21\u4e16\u4ee3\u6cbb\u7642\u3092\u76ee\u6307\u3057\u305f\u5148\u7aef\u7684\u7814\u7a76\u300d\u201c\u816b\u760d\u8840\u7ba1\u306e\u7570\u5e38\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d2016. 1. 21 (\u6a2a\u6d5c)<\/li>\n<\/ol>\n

                      2015<\/h4>\n
                        \n
                      1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c38\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u300c\u8840\u7ba1\uff65\u4ee3\u8b1d\u7570\u5e38\u306e\u52d5\u7684\u5909\u5316\u3092\u63a2\u308b\u30a8\u30d4\u30b2\u30ce\u30df\u30af\u30b9\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u907a\u4f1d\u5b50\u767a\u73fe\u7570\u5e38\u3068\u30a8\u30d4\u30b2\u30ce\u30e0\u201d 2015\uff0e12\uff0e3\uff08\u795e\u6238\uff09<\/li>\n
                      2. Hida K<\/u>.\uff1aTumor Endothelial Cells as Key Players in Tumor Metastasis\uff0c2015 Asian-Australian Vascular Biology Meeting (AAVBM)\uff0c2015.10.15 (Busan, Korea)<\/li>\n
                      3. Hida K<\/u>.\uff1aTumor Endothelial Cells as Key Players in Tumor Metastasis\uff0cKAIST Vascular Biology Mini-Symposium 2015\uff0c2015.10.14 (Daejeon, Korea)<\/li>\n
                      4. Hida K<\/u>.\uff1aTumor endothelial cells and cancer progression\uff0c\u7b2c74\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c2015.10.10\uff08\u540d\u53e4\u5c4b\uff09<\/li>\n
                      5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c67\u56de\u65e5\u672c\u7d30\u80de\u751f\u7269\u5b66\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u907a\u4f1d\u5b50\u767a\u73fe\u5236\u5fa1\u306e\u7570\u5e38\u304c\u5c0e\u304f\u6052\u5e38\u6027\u7834\u7dbb\u3068\u75be\u60a3\u300d,\u201c\u816b\u760d\u8840\u7ba1\u306e\u907a\u4f1d\u5b50\u767a\u73fe\u7570\u5e38\u3068\u304c\u3093\u306e\u60aa\u6027\u5316\u201d\uff0c2015.6.30\uff08\u6771\u4eac\uff09<\/li>\n
                      6. Maishi N.,\u00a0Hida K<\/u>.\uff1aSpring Special Symposium of the Japanese Vascular Biology and Medicine Organization,\u201cTumor endothelial cells instigate metastasis of indolent tumors\u201d,2015.5.13\uff08Osaka, Japan\uff09<\/li>\n
                      7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c104\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u660e\u65e5\u306e\u75c5\u7406\u5b66\u3092\u62d3\u304f 2\u65b0\u6280\u8853\u30fb\u65b0\u6982\u5ff5\u304c\u62d3\u304f\u6b21\u4e16\u4ee3\u75c5\u7406\u5b66\u300d\uff0c\u201c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u306e\u7279\u7570\u6027\u201d, 2015.5.1\uff08\u540d\u53e4\u5c4b\uff09<\/li>\n
                      8. \u9593\u77f3\u5948\u6e56\uff0c\u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c33\u56de \u65e5\u672c\u53e3\u8154\u816b\u760d\u5b66\u4f1a\u7dcf\u4f1a\uff65\u5b66\u8853\u5927\u4f1a,\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u304c\u3093\u8ee2\u79fb\u4fc3\u9032\u6a5f\u69cb\u201d\uff0c2015.1.30\uff08\u5948\u826f\uff09<\/li>\n<\/ol>\n

                        2014<\/h4>\n
                          \n
                        1. Maishi N.,\u00a0Hida K<\/u>.\uff1aThe 17th HU-SNU JOINT SYMPOSIUM \u201cCharacterization of tumor endothelial cells for development of new anti-angiogenic therapy\u201d, 2014.11.28\uff08Sapporo, Japan\uff09<\/li>\n
                        2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5317\u6d77\u9053\u5927\u5b66\u907a\u4f1d\u5b50\u75c5\u5236\u5fa1\u7814\u7a76\u6240\u30fb\u91d1\u6ca2\u5927\u5b66\u304c\u3093\u9032\u5c55\u5236\u5fa1\u7814\u7a76\u6240\u30b8\u30e7\u30a4\u30f3\u30c8\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02014\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u7570\u5e38\u6027\u7372\u5f97\u30e1\u30ab\u30cb\u30ba\u30e0\u306b\u3064\u3044\u3066\u201d\uff0c2014.10.27\uff08\u672d\u5e4c\uff09<\/li>\n
                        3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c1\u56de\u7d30\u80de\u5916\u5c0f\u80de\u5b66\u4f1a\uff0c\u201cTumor-derived exosome miRNA induce abnormality in tumor endothelial cells\u201d\uff0c2014.8.28\uff08\u5e83\u5cf6\uff09<\/li>\n
                        4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u91d1\u6ca2\u5973\u6027\u304c\u3093\u7814\u7a76\u8005\u30d5\u30a9\u30fc\u30e9\u30e0\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u3068\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u958b\u767a\u201d2014.7.30\uff08\u91d1\u6ca2\uff09<\/li>\n
                        5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c41\u56de\u65e5\u672c\u6bd2\u6027\u5b66\u4f1a\u5b66\u8853\u5e74\u4f1a\u30df\u30cb\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u8010\u6027\u306e\u65b0\u305f\u306a\u30e1\u30ab\u30cb\u30ba\u30e0\uff1a\u8fb2\u85ac\u304b\u3089\u6297\u304c\u3093\u5264\u3001\u6297\u30a6\u30a3\u30eb\u30b9\u85ac\u307e\u3067\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u85ac\u5264\u62b5\u6297\u6027\u201d\uff0c2014.7.4\uff08\u795e\u6238\uff09<\/li>\n
                        6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u516c\u958b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u8840\u7ba1\u3092\u6a19\u7684\u3068\u3059\u308b\u30ca\u30ce\u533b\u7642\u306e\u5b9f\u7528\u5316\u306b\u5411\u3051\u3066\u62e0\u70b9\u5f62\u6210\uff5e\u304c\u3093\u3092\u59cb\u3081\u3068\u3059\u308b\u56fd\u6c11\u75c5\u3092\u8840\u7ba1\u304b\u3089\u6cbb\u7642\u3059\u308b\uff5e\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u591a\u69d8\u6027\u89e3\u660e\u3068\u500b\u5225\u5316\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u6cd5\u306e\u958b\u767a\u201d2014.6.27\uff08\u672d\u5e4c\uff09<\/li>\n
                        7. \u9593\u77f3\u5948\u6e56<\/u>\uff1a\u516c\u958b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u8840\u7ba1\u3092\u6a19\u7684\u3068\u3059\u308b\u30ca\u30ce\u533b\u7642\u306e\u5b9f\u7528\u5316\u306b\u5411\u3051\u3066\u62e0\u70b9\u5f62\u6210\uff5e\u304c\u3093\u3092\u59cb\u3081\u3068\u3059\u308b\u56fd\u6c11\u75c5\u3092\u8840\u7ba1\u304b\u3089\u6cbb\u7642\u3059\u308b\uff5e\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u591a\u69d8\u6027\u89e3\u660e\u3068\u500b\u5225\u5316\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u6cd5\u306e\u958b\u767a\u201d, 6.27\uff08\u672d\u5e4c\uff09<\/li>\n
                        8. Maishi N.,\u00a0Hida K<\/u>.\uff1a17th International Congress on Oral Pathology and Medicine, \u201cCharacterization of tumor endothelial cells for development of new anticancer drugs\u201d, 2014.5.26 (Istanbul, Turkey)<\/li>\n
                        9. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c68\u56deNPO\u6cd5\u4eba\u65e5\u672c\u53e3\u8154\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u304c\u3093\u3092\u9593\u8cea\u304b\u3089\u8003\u3048\u308b\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u3068\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u958b\u767a\u201d\uff0c2014.5.8\uff08\u6771\u4eac\uff09<\/li>\n
                        10. Hida K.<\/u>\uff1a\u201dTumor endothelial cells as key players in tumor microenvironment.\u201d International Symposium on Vascular Biology and Medicine, 2014.4.18\uff08Sendai, Japan\uff09<\/li>\n
                        11. Hida K.<\/u>\uff1a\u201dHeterogeneity of tumor endothelium\u201d, The 18th International Vascular Biology Meeting, 2014. 4.14-17, Kyoto, Japan<\/li>\n<\/ol>\n

                          2013<\/h4>\n
                            \n
                          1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c36\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u30de\u30a4\u30af\u30edRNA\u3068\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u306e\u751f\u7269\u5b66\u7684\u610f\u7fa9\u300d,\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\u3068miRNA\u201d, 2013.12.5\uff08\u795e\u6238\uff09<\/li>\n
                          2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c3\u56de\u5317\u6d77\u9053\u63a2\u7d22\u75c5\u7406\u5b66\u7814\u7a76\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u63a2\u7d22\u533b\u7642\u30fb\u57fa\u790e\u3068\u81e8\u5e8a\u306e\u9023\u643a\uff1a\u75c5\u7406\u304c\u6a4b\u6e21\u3057\u3059\u308b\u81e8\u5e8a\u7814\u7a76\u306e\u65b0\u5c55\u958b\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u89e3\u660e\u304b\u3089\u8a3a\u65ad\u30fb\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u201d\uff0c2013.11.9\uff08\u672d\u5e4c\uff09<\/li>\n
                          3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c46\u56de\u5317\u6d77\u9053\u75c5\u7406\u8ac7\u8a71\u4f1a\u7279\u5225\u8b1b\u6f14,\u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u3068\u304c\u3093\u306e\u6d78\u6f64\u8ee2\u79fb\u201d, 2013.10.12\uff08\u672d\u5e4c\uff09<\/li>\n
                          4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c72\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u304c\u3093\u3068\u5fae\u5c0f\u74b0\u5883\uff1a\u7814\u7a76\u306e\u5c55\u671b\u300d,\u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u201d, 2013.10.3\uff08\u6a2a\u6d5c\uff09<\/li>\n
                          5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c21\u56de\u65e5\u672c\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u816b\u760d\u8840\u7ba1\u65b0\u751f\u300d\uff0c\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u85ac\u5264\u62b5\u6297\u6027\u201d, 2013.9.26\uff08\u5927\u962a\uff09<\/li>\n
                          6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c25\u56de\u5317\u6d77\u9053\u8f38\u8840\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0c\u201c\u816b\u760d\u8840\u7ba1\u65b0\u751f\u3068\u304c\u3093\u306e\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u201d\uff0c2013.7.26\uff08\u672d\u5e4c\uff09<\/li>\n
                          7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u304c\u3093\u8ee2\u79fb\u3068\u8840\u7ba1\u65b0\u751f, \u7b2c22\u56de\u65e5\u672c\u304c\u3093\u8ee2\u79fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a, 2013.7.12\uff08\u677e\u672c\uff09<\/li>\n
                          8. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u816b\u760d\u8840\u7ba1\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u201d, 2013.4.18\uff08\u4eac\u90fd\uff09<\/li>\n<\/ol>\n

                            2012<\/h4>\n
                              \n
                            1. Hida K.<\/u>\uff1a\u201cHeterogeneity of Tumor Endothelial Cells.\u201dThe 43rd International Symposium of The Princess Takamatsu Cancer Research Fund\u201cCancer Heterogeneity: Impact on Carcinogenesis, Cancer Stem Cell, Microenvironment, Diagnosis and Treatment\u201d 2012.11.15\uff08Tokyo, Japan\uff09<\/li>\n
                            2. Hida K.<\/u>\uff1a\u201cAltered phenotype in endothelial cells in tumor microenvironment.\u201dThe 2nd International Symposium by JSPS Core-to-Core Program\u201cCooperative International Framework in TGF-\u03b2 Family Signaling\u201d 2012.10.30\uff08Tokyo, Japan\uff09<\/li>\n
                            3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c57\u56de\u65e5\u672c\u53e3\u8154\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300c\u304c\u3093\u6cbb\u7642\u6226\u7565\u3092\u76ee\u6307\u3057\u305f\u5148\u7aef\u7684\u304c\u3093\u7814\u7a76\u300d, \u201c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u3068\u8840\u7ba1\u65b0\u751f\u201d, 2012.10.21\uff08\u6a2a\u6d5c\uff09<\/li>\n
                            4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c43\u56dePFA\u56fd\u969b\u6b6f\u5b66\u4f1a\u65e5\u672c\u90e8\u4f1a\u5e74\u6b21\u5927\u4f1a\uff0d\u30d4\u30a8\u30fc\u30eb\u30d5\u30a9\u30fc\u30b7\u30e3\u30eb\u30a2\u30ab\u30c7\u30df\u30fc\u56fd\u969b\u6b6f\u5b66\u4f1a\u65e5\u672c\u90e8\u4f1a, \u201c\u8840\u7ba1\u3092\u6a19\u7684\u3068\u3057\u305f\u65b0\u898f\u6297\u304c\u3093\u5264\u306e\u958b\u767a\u3092\u76ee\u6307\u3057\u3066\u201d, 2012.9.29\uff08\u672d\u5e4c\uff09<\/li>\n
                            5. Hida K.<\/u>\uff1a\u201cCrosstalk between tumor endothelial cells and tumor cells.\u201dThe 71st Annual Meeting of the Japanese Cancer Association, 2012.9.21\uff08Sapporo, Japan\uff09<\/li>\n
                            6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5e83\u5cf6\u5927\u5b66\u5973\u6027\u7814\u7a76\u8005\u30b9\u30ad\u30eb\u30a2\u30c3\u30d7\u4ea4\u6d41\u4f1a, \u201c\u6bcd\u89aa\u3068\u3057\u3066, PI\uff08Principle Investigator\uff09\u3068\u3057\u3066\u201d, 2012.7.13\uff08\u5e83\u5cf6\uff09<\/li>\n
                            7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c28\u56de\u65e5\u672cDDS\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u201c\u304c\u3093\u306e\u6d78\u6f64\u8ee2\u79fb\u3068\u8840\u7ba1\u65b0\u751f\u201d, 2012.7.4\uff08\u672d\u5e4c\uff09<\/li>\n
                            8. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c101\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\uff17\u300c\u53e3\u8154\u764c\u306e\u60aa\u6027\u5f62\u8cea\u306e\u767a\u73fe\u306b\u95a2\u3059\u308b\u6a4b\u6e21\u3057\u7814\u7a76\u3068\u5206\u5b50\u6a19\u7684\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u300d\u3001\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\u3068\u8ee2\u79fb\u3068\u306e\u95a2\u9023\u201d, 2012.4.28\uff08\u6771\u4eac\uff09<\/li>\n
                            9. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5343\u91cc\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30bb\u30df\u30ca\u30fc\u300c\u304c\u3093\u306e\u6d78\u6f64\u30fb\u8ee2\u79fb\u3068\u5fae\u5c0f\u74b0\u5883\u300d\uff0c\u201c\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u6297\u304c\u3093\u5264\u62b5\u6297\u6027\u201d\uff0c2012.2.24\uff08\u5927\u962a\uff09<\/li>\n
                            10. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c30\u56de\u65e5\u672c\u53e3\u8154\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u53e3\u8154\u764c\u306e\u6d78\u6f64\uff0d\u30de\u30af\u30ed\u30fb\u30df\u30af\u30ed\u30fb\u30e2\u30ec\u30ad\u30e5\u30e9\u30fc\u300d, \u201c\u304c\u3093\u306e\u6d78\u6f64\u8ee2\u79fb\u3068\u8840\u7ba1\u65b0\u751f\u201d, 2012.1.26\uff08\u5927\u5bae\uff09<\/li>\n
                            11. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u516c\u958b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u8840\u7ba1\u3092\u6a19\u7684\u3068\u3059\u308b\u9769\u65b0\u7684\u533b\u85ac\u5206\u5b50\u9001\u9054\u6cd5\u306e\u57fa\u76e4\u6280\u8853\u306e\u78ba\u7acb\u300d, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\u306e\u89e3\u660e\u201d, 2012.1.12\uff08\u672d\u5e4c\uff09<\/li>\n<\/ol>\n

                              2011<\/h4>\n
                                \n
                              1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1aRecent Advance in Tumor Angiogenesis 2011, \u201c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\u3068\u304c\u3093\u306e\u8ee2\u79fb\u201d, 2011.12.3\uff08\u6d5c\u677e\uff09<\/li>\n
                              2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u51fd\u9928Basic Cancer Forum, \u201c\u816b\u760d\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u5c40\u9762-Lesson from Basic research\u201d, 2011.11.24\uff08\u51fd\u9928\uff09<\/li>\n
                              3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u5e73\u621023\u5e74\u5ea6\u907a\u4f1d\u5b50\u75c5\u5236\u5fa1\u7814\u7a76\u6240\u5171\u540c\u7814\u7a76\u96c6\u4f1a, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\u304c\u3082\u305f\u3089\u3059\u304c\u3093\u6cbb\u7642\u3078\u306e\u5f71\u97ff\u201d, 2011.9.6\uff08\u672d\u5e4c\uff09<\/li>\n
                              4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u5927\u962a\u6b6f\u79d1\u5927\u5b66\u5927\u5b66\u966250\u5468\u5e74\u8a18\u5ff5\u8b1b\u6f14\u4f1a\u3001\u201c\u816b\u760d\u8840\u7ba1\u7279\u7570\u6027\u306e\u89e3\u660e\u3068\u65b0\u305f\u306a\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u3078\u306e\u5fdc\u7528\u201d, 2011.9.2\uff08\u5927\u962a\uff09<\/li>\n
                              5. Hida K<\/u>.<\/u>\uff1a<\/strong>\u201cA New Insights into Tumor endothelial cell\u201d, The 5th Meeting of Asian Society of Oral and Maxillofacial Pathology, 2011.8.24\uff08Fukuoka, Japan\uff09<\/li>\n
                              6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u7b2c63\u56de\u65e5\u672c\u7d30\u80de\u751f\u7269\u5b66\u4f1a\u5927\u4f1a\u3001\u201c\u8840\u7ba1\u306e\u591a\u69d8\u6027\uff5e\u7d44\u7e54\u767a\u751f\u304b\u3089\u75be\u60a3\u306b\u304a\u3051\u308b\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u201d, 2011.6.29\uff08\u672d\u5e4c\uff09<\/li>\n
                              7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>ACCEL in Hokkaido\uff5eNSCLC\u306b\u5bfe\u3059\u308b\u30a2\u30d0\u30b9\u30c1\u30f3\u306e\u6cbb\u7642\u6226\u7565\uff5e, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027\u3068\u305d\u306e\u5236\u5fa1\u201d, 2011.6.18\uff08\u672d\u5e4c\uff09<\/li>\n
                              8. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u7b2c27\u56de\u65e5\u672cDDS\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u591a\u69d8\u306a\u751f\u7269\u50cf\u201d, 2011.6.9\uff08\u6771\u4eac\uff09<\/li>\n
                              9. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u9ad8\u77e5\u5927\u5b66\u533b\u5b66\u90e8\u6b6f\u79d1\u53e3\u8154\u5916\u79d1\u5b66\u8b1b\u5ea7\u30bb\u30df\u30ca\u30fc, \u201c\u304c\u3093\u7d44\u7e54\u306b\u304a\u3051\u308b\u8840\u7ba1\u306e\u7279\u7570\u6027\u306e\u89e3\u660e\u3068\u65b0\u305f\u306a\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u3078\u306e\u5fdc\u7528\u201d, 2011.6.3\uff08\u9ad8\u77e5\uff09<\/li>\n
                              10. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u7b2c100\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u30df\u30fc\u30c6\u30a3\u30f3\u30b04\u300c\u53e3\u8154\u764c\u306e\u6d78\u6f64\uff1a\u5916\u79d1\u75c5\u7406\u3068\u5206\u5b50\u75c5\u7406\u306e\u67b6\u3051\u6a4b\u300d, \u201c\u764c\u9593\u8cea\u306e\u7570\u5e38, \u3068\u304f\u306b\u816b\u760d\u8840\u7ba1\u306e\u7279\u6027\u3068\u6d78\u6f64\u3068\u306e\u95a2\u9023\u6027\u201d, 2011.5.1\uff08\u6771\u4eac\uff09<\/li>\n
                              11. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u7b2c\uff19\u56de\u53e3\u8154\u533b\u79d1\u5b66\u30d5\u30ed\u30f3\u30c6\u30a3\u30a2\u5b66\u8853\u96c6\u4f1a, \u304c\u3093\u5fae\u5c0f\u74b0\u5883\u5185\u306b\u304a\u3051\u308b\u816b\u760d\uff0d\u8840\u7ba1\u306e\u76f8\u4e92\u4f5c\u7528, 2011.3.5\uff08\u798f\u5ca1\uff09<\/li>\n
                              12. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>The 8th Annual Meeting for the Japanese Association for Cancer and Hypoxia Research, \u201c\u4f4e\u9178\u7d20\u74b0\u5883\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u201d, 2011.1.29-30\uff08\u672d\u5e4c\uff09<\/li>\n<\/ol>\n

                                2010<\/h4>\n
                                  \n
                                1. Hida K<\/u>. :\u00a0<\/strong>\u201cCrosstalk between Tumor Endothelial Cells and Microenvironment.\u201d\u00a0The 13th Hokkaido University \u2013 Seoul National University Joint Sympojium<\/em>, 26th Nov, 2010 (Sapporo)<\/li>\n
                                2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u7b2c56\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u79cb\u671f\u7279\u5225\u7dcf\u4f1a, \u201cCrosstalk between tumor endothelial cells and microenvironment\u201d, 2010.11.26\uff08\u5317\u4e5d\u5dde\uff09<\/li>\n
                                3. Hida K<\/u>. Crosstalk between blood vessels and tumor\u3000microenvironment. The Meeting of the 20th Anniversary Celebration of the Sister School Affiliation between Graduate School of Dental Medicine, Hokkaido University and School of Dentistry, Chonbuk National University\uff1a2010 Oct 14\uff1aSapporo, Japan<\/li>\n
                                4. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u5e73\u621022\u5e74\u5ea6\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u79cb\u5b63\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u816b\u760d\u8840\u7ba1\u65b0\u751f\u306e\u57fa\u790e\u3068\u81e8\u5e8a\u300d, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u3092\u6a19\u7684\u3068\u3057\u305f\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u201d, 2010.10.9\uff08\u672d\u5e4c\uff09<\/li>\n
                                5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u7b2c64\u56de\u65e5\u672c\u53e3\u8154\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u3068\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u201d, 2010.6.24-25\uff08\u672d\u5e4c\uff09<\/li>\n
                                6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u7b2c43\u56de\u52a0\u9f62\u533b\u5b66\u7814\u7a76\u6240\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u8840\u7ba1\u304b\u3089\u898b\u308b\u533b\u79d1\u5b66\u7814\u7a76\u306e\u65b0\u5c55\u958b\u300d, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\u3068\u6cbb\u7642\u62b5\u6297\u6027\u201d, \uff08\u4ed9\u53f0\uff092010.3.24<\/li>\n
                                7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>The 4th Lecture Meeting SUTENT by Urology Specialist, \u201c\u304c\u3093\u6cbb\u7642\u306e\u6700\u524d\u7dda\u3000\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u306e\u6700\u65b0\u30a2\u30d7\u30ed\u30fc\u30c1\u201d, 2010.2.26\uff08\u6771\u4eac)<\/li>\n
                                8. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a<\/strong>\u516c\u958b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u751f\u4f53\u30ca\u30ce\u74b0\u5883\u306e\u6642\u7a7a\u9593\u5236\u5fa1\u3092\u76ee\u6307\u3057\u3066\u300d\u3001\u6226\u7565\u7684\u7814\u7a76\u63a8\u9032\u7d4c\u8cbb\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u4e3b\u50ac\u300c\u8840\u7ba1\u3092\u6a19\u7684\u3068\u3059\u308b\u9769\u65b0\u7684\u533b\u85ac\u5206\u5b50\u9001\u9054\u6cd5\u306e\u57fa\u76e4\u6280\u8853\u306e\u78ba\u7acb\u300d, \u201c\u751f\u4f53\u30ca\u30ce\u74b0\u5883\u3092\u69cb\u6210\u3059\u308b\u9593\u8cea\u7d30\u80de\u306e\u6642\u7a7a\u9593\u7684\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u306e\u89e3\u660e\u201d, 2010.1.5, \u5317\u6d77\u9053\u5927\u5b66\u5927\u5b66\u9662\u85ac\u5b66\u7814\u7a76\u9662\u81e8\u5e8a\u85ac\u5b66\u8b1b\u7fa9\u5ba4\uff08\u672d\u5e4c\uff09<\/li>\n<\/ol>\n

                                  2009<\/h4>\n
                                    \n
                                  1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c32\u56de\u65e5\u672c\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u5e74\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u3068\u85ac\u5264\u62b5\u6297\u6027\u201d, 2009.12.12\uff08\u6a2a\u6d5c\uff09<\/li>\n
                                  2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c17\u56de\u65e5\u672c\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\u201d, 2009.10.8\uff08\u6771\u4eac\uff09<\/li>\n
                                  3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u6625\u671f\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u95a2\u3059\u308b\u65b0\u3057\u3044\u6d1e\u5bdf\uff0d\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u5185\u76ae\u306e\u7279\u7570\u6027\u201c, 2009.6.30\uff08\u672d\u5e4c\uff09<\/li>\n<\/ol>\n

                                    2008\u5e74\u4ee5\u524d<\/h4>\n
                                      \n
                                    1. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u65e5\u672c\u751f\u5316\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u30fb\u65e5\u672c\u751f\u7269\u7269\u7406\u5b66\u4f1a\u5317\u6d77\u9053\u652f\u90e8\u30fb\u5317\u6d77\u9053\u5206\u5b50\u751f\u7269\u7814\u7a76\u4f1a\uff12\uff10\uff10\uff18\u5e74\u5ea6\u5408\u540c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u751f\u547d\u73fe\u8c61\u306e\u5206\u5b50\u30ec\u30d9\u30eb\u3067\u306e\u89e3\u660e\u300d
                                      \n\u300c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\u300d, 2008.11.21\u3001\u5317\u6d77\u9053\u5927\u5b66\u5927\u5b66\u9662\u7406\u5b66\u7814\u7a76\u9662\u5927\u8b1b\u7fa9\u5ba4\uff08\u672d\u5e4c\uff09<\/li>\n
                                    2. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u91d1\u6ca2\u5927\u5b66\u304c\u3093\u7814\u7a76\u6240\u30bb\u30df\u30ca\u30fc, \u300c\u816b\u760d\u8840\u7ba1\u306e\u591a\u69d8\u6027\uff0d\u7279\u7570\u7684\u306a\u907a\u4f1d\u5b50\u767a\u73fe\u304b\u3089\u67d3\u8272\u4f53\u7570\u5e38\u307e\u3067\uff0d\u300d, 2008.5.16\uff08\u91d1\u6ca2)<\/li>\n
                                    3. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c\uff11\u56de\u6d88\u5316\u5668\u30ea\u30b5\u30fc\u30c1\u30bb\u30df\u30ca\u30fc\u3000\u7279\u5225\u8b1b\u6f14\u300c\u816b\u760d\u8840\u7ba1\u65b0\u751f\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9\uff0d\u591a\u69d8\u306a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u6027\uff0d\u300d, 2008.4.25\uff08\u5e83\u5cf6\uff09<\/li>\n
                                    4. Hida K<\/u>, Klagsbrun M, Hida Y and Shindoh M. \u201cChromosomal Abnormalities of Human Tumor-Associated Endothelial Cells\u201d THE U.S.-JAPAN COOPERATIVE CANCER RESEARCH PROGRAM WORKSHOP \uff08NCI-JSPS Joint Workshop\uff09\uff1a2008 Mar 19-21\uff1aKyoto Japan.<\/li>\n
                                    5. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a2007\u65e5\u672c\u751f\u5316\u30fb\u5206\u5b50\u751f\u7269\u5b66\u4f1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u201c\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7570\u5e38\u6027\u201d, 2007.12.14\uff08\u6a2a\u6d5c\uff09<\/li>\n
                                    6. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1aBasic Urology Research Seminar \u201d\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u7279\u7570\u6027 \u7406\u60f3\u7684\u306a\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u3092\u958b\u767a\u3059\u308b\u305f\u3081\u306b\u201d, 2007.8.25\uff08\u767b\u5225\uff09<\/li>\n
                                    7. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u6625\u671f\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u62db\u5f85\u8b1b\u6f14\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u95a2\u3059\u308b\u65b0\u3057\u3044\u6d1e\u5bdf\uff0d\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306b\u304a\u3051\u308b\u8840\u7ba1\u5185\u76ae\u306e\u7279\u7570\u6027\u201c, 2007.6.30\uff08\u672d\u5e4c\uff09<\/li>\n
                                    8. Hida K*.<\/strong><\/u>, Klagsbrun M., Hida Y. and Shindoh M.: Abnormality of tumor endothelial cells. International sessions 2 Cancer Angiogenesis.\u3000The 66th Annual Meeting of the Japanese Cancer Association, 2007.10.3-5 (Yokohama,Japan)<\/li>\n
                                    9. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u6771\u4eac\u5927\u5b66\u5927\u5b66\u9662\u533b\u5b66\u7cfb\u7814\u7a76\u79d1\u5206\u5b50\u75c5\u7406\u5b66\u8b1b\u5ea7\u30bb\u30df\u30ca\u30fc \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u95a2\u3059\u308b\u65b0\u3057\u3044\u6d1e\u5bdf\u201d, 2006.12.15\uff08\u6771\u4eac)<\/li>\n
                                    10. Hida K.<\/u>: The COE 3rd International Symposium\uff5eNovel perspectives in cancer research and translation to the clinic\u201cUnderstanding Abnormality of Tumor Endothelial Cells to Develop Ideal Antiangiogenic Therapies\u201d 2006.11.9\uff08Sendai, Japan\uff09<\/li>\n
                                    11. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u65ed\u5ddd\u80ba\u764c\u7814\u7a76\u4f1a\u5b66\u8853\u5927\u4f1a\u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u95a2\u3059\u308b\u65b0\u3057\u3044\u6d1e\u5bdf\uff0d\u3088\u308a\u52b9\u679c\u7684\u306a\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u3092\u76ee\u6307\u3057\u3066\uff0d\u201d, 2006.4.28\uff08\u65ed\u5ddd\uff09<\/li>\n
                                    12. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u5927\u962a\u5927\u5b66\u5927\u5b66\u9662\u533b\u5b66\u7cfb\u7814\u7a76\u79d1\u6a5f\u80fd\u8a3a\u65ad\u79d1\u5b66\u8b1b\u5ea7\u5206\u5b50\u75c5\u7406\u5b66\u6559\u5ba4\u30bb\u30df\u30ca\u30fc, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u7570\u5e38\u6027\u201d, 2005.12.5\uff08\u5927\u962a\uff09<\/li>\n
                                    13. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c\uff16\u56de \u611b\u5a9b\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u30d5\u30a9\u30fc\u30e9\u30e0\u201d\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u3064\u3044\u3066\u306e\u65b0\u3057\u3044\u6d1e\u5bdf\u201d, 2005.11.25\uff08\u611b\u5a9b\uff09<\/li>\n
                                    14. Hida K*.<\/strong><\/u>: AACR Special Conference in Cancer Research \u201cAnti-Angiogenesis and Drug Delivery to tumors:Bench to Bedside and Back\u201d Tumor-associated endothelial cells with cytogenetic abnormalities\u201c 2005.11.9-13 (Boston)<\/li>\n
                                    15. \u6a0b\u7530\u4eac\u5b50<\/u>\u3001\u6a0b\u7530\u6cf0\u6d69, \u5c0f\u6797\u6b63\u4f38, \u9032\u85e4\u6b63\u4fe1, Michael Klagsbrun\uff1a\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u3064\u3044\u3066\u306e\u65b0\u3057\u3044\u6d1e\u5bdf, \u7b2c85\u56de\u5317\u6d77\u9053\u764c\u8ac7\u8a71\u4f1a\u79cb\u671f\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u8840\u7ba1\u65b0\u751f\u306e\u65b0\u3057\u3044\u30d1\u30e9\u30c0\u30a4\u30e0\u3068\u764c\u300d, 2005.11.5\uff08\u672d\u5e4c\uff09<\/li>\n
                                    16. \u6a0b\u7530\u4eac\u5b50<\/u>\uff1a\u7b2c85\u56de\u764c\u8ac7\u8a71\u4f1a \u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u3064\u3044\u3066\u306e\u65b0\u3057\u3044\u6d1e\u5bdf\uff0d\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306e\u67d3\u8272\u4f53\u7570\u5e38\u3000\u30df\u30cb\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, 2005.9.3\uff08\u672d\u5e4c\uff09<\/li>\n
                                    17. Hida K*.<\/u>:<\/strong>Boston Angiogenesis Meeting: BAM: \u201cTumor-associated endothelial cells with cytogenetic abnormalities\u201d 2004.11.5 (Boston)<\/li>\n
                                    18. Hida K*.<\/strong><\/u>:<\/strong>Gordon symposium\uff1a\u201dChromosome instability of Tumor associated Endothelial cells \u201c2004.8.23 (Andover, NH, USA)<\/li>\n
                                    19. Hida K<\/u>. Tumor Endothelial cells are not normal. Harvard Medical School Surgical Research Spring Seminar\uff1a2003 Apr\uff1aBoston, U.S.A.<\/li>\n
                                    20. Hida K<\/u>. Characterization of Tumor-deirived Endothelial cells. Harvard Medical School Surgical Research Summer Retreat Seminar\uff1a2002 Jul\uff1aBoston, U.S.A.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                                      2025 \u6a0b\u7530\u4eac\u5b50\uff1aIOC\u7642\u6cd5\u7814\u7a76\u4f1a\u5b9a\u671f\u96c6\u4f1a2026, \u201c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u708e\u75c7\u6027\u5f62\u8cea\u3068\u304c\u3093\u6cbb\u7642\u201d, 2026.2.6\uff08\u798f\u5cf6\u958b\u50ac, Web\u63a5\u7d9a\u306b\u3066\u30ea\u30e2\u30fc\u30c8\u8b1b\u6f14\uff09 Hida K\uff1a2025 Annual Meeting of the Korean Society for Vascular Biology and Medicine (KVBM), \u201cTumor Endothelial Cells and…\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":18,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"publications.php","meta":{"footnotes":""},"class_list":["post-130","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/comments?post=130"}],"version-history":[{"count":85,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/130\/revisions"}],"predecessor-version":[{"id":1510,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/130\/revisions\/1510"}],"up":[{"embeddable":true,"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/pages\/18"}],"wp:attachment":[{"href":"https:\/\/www.den.hokudai.ac.jp\/vascular-biol-pathol\/wp-json\/wp\/v2\/media?parent=130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}